Advancis Pharmaceutical Corp., of Germantown, Md., promoted David Kudla to vice president of quality assurance.

Aethlon Medical Inc., of San Diego, appointed Charles Bailey to its science advisory board.

Akorn Inc., of Buffalo Grove, Ill., appointed Jeffrey Whitnell vice president of finance and chief financial officer.

Alexza Molecular Delivery Corp., of Palo Alto, Calif., appointed James Cassella senior vice president of research and development.

Alnylam Pharmaceueticals Inc., of Cambridge, Mass., appointed Patricia Allen vice president of finance.

Altachem Pharma Ltd., of Edmonton, Alberta, elected Robert Sydenham, Ragupathy Madiyalakan, Ian McConnan, Selvaraj Naicker and Warren Jackson to its board. Sydenham took on the role of chairman, and Altachem also appointed Naicker interim chief operating officer, and Jackson executive vice president of international business.